• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What are Clinical Trials?
    • Become a Clinical Trial Volunteer
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » PathoQuest partners with Charles River Laboratories

PathoQuest partners with Charles River Laboratories

September 30, 2016
CenterWatch Staff

PathoQuest, a rapidly growing biotechnology company spun out from Institut Pasteur, has announced a preferred partnership with Charles River Laboratories, an early-stage CRO, to provide an improved Viral Safety Service offering to biopharmaceutical companies. While traditional molecular approaches to safety testing are limited to the identification of a limited, predefined list of viruses, the PathoQuest’s next generation sequencing (NGS) solution combines a proprietary curated virus database with an automated analysis pipeline. This provides a universal test for identifying viruses of any type in a single, comprehensive analysis that minimizes false negatives.

“We are very pleased to enter into this partnership with PathoQuest and look forward to offering this unique NGS-based testing solution to our customers,” stated Horst Ruppach, global director, Viral Clearance and Virology at Charles River Laboratories. “We believe this advanced viral safety testing solution is an important supplement to ensuring the safety of biological products produced by the biopharmaceutical industry.”

“Charles River’s global footprint and extensive experience in biologics testing opens a great opportunity for biopharmaceutical companies to access our NGS-based solutions,” said Jean-François BREPSON, president and CEO of PathoQuest. “In a challenging regulatory environment, we anticipate that PathoQuest’s NGS-based viral safety test will become the new gold standard in biosafety assessment.”

With this partnership agreement, PathoQuest demonstrates its unique know-how and expertise in the field of pathogen identification with a fully-integrated, NGS-based metagenomics process for identifying pathogens from biological specimens and samples and the delivery of an actionable report.

In the wake of viral contaminants of several high-profile marketed biological products, the biopharmaceutical industry is increasingly looking for improved methods for viral safety testing of biological products such as monoclonal antibodies or vaccines.

    Upcoming Events

    • 05Dec

      Thriving in Clinical Research – Overcoming Common Challenges as a Site: Part 3 – Site Resourcing

    • 14Apr

      MAGI 2024: The Clinical Research Conference

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Jonathan Seltzer

      Thought Leadership: Remote Patient Monitoring Gives New View of Safety in Cardiac Clinical Trials

    • Quality_Compass-360x240.png

      Ask the Experts: Applying Quality by Design to Protocols

    • Obesity Treatment Patient

      Clinical Trials Need Greater Representation of Obese Patients, Experts Say

    • Modernize-360x240.png

      FDA IT Modernization Plan Prioritizes Data-Sharing, AI, Collaboration and More

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing